Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company’s Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during Wells Fargo’s 2024 Healthcare Conference on Wednesday, September 4, at 2:15 PM Eastern Time (11:15 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 7,700 employees, and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

Contacts

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.27
+7.32 (3.64%)
AAPL  253.79
+7.16 (2.90%)
AMD  203.43
+7.39 (3.77%)
BAC  48.75
+1.52 (3.22%)
GOOG  286.86
+13.72 (5.02%)
META  572.13
+35.75 (6.67%)
MSFT  370.17
+11.21 (3.12%)
NVDA  174.40
+9.23 (5.59%)
ORCL  147.11
+8.31 (5.99%)
TSLA  371.75
+16.47 (4.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.